Trial Profile
Fluticasone propionate delivered with a novel bi-directional delivery device in patients with chronic rhinosinusitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Aug 2011
Price :
$35
*
At a glance
- Drugs Fluticasone propionate (Primary)
- Indications Rhinosinusitis
- Focus Therapeutic Use
- 08 Aug 2011 New trial record